info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
in IN: +91-826-083-6500
Home » Medical Devices »

Cardiac Pacemaker Market By Type (Conventional Pacemakers, MRI Compatible Pacemakers), End-User (Hospitals & Cardiac Centers, ASCs (Ambulatory Surgical Centers), Others) By Geography, Segment revenue estimations, Forecast: 2021-2028

Published On: Jan-2022   |   Base Year: 2000   |   No Of Pages: 135   |   Historical Data: 2015 - 2019   |   Formats: PDF   |   Report ID: 19775298

In 2020, the Global Cardiac Pacemaker Market share was USD 4.73 billion. It is predicted to reach USD 6.78 billion by 2030, representing a CAGR of 3.68 percent throughout the forecasted period.

 

Market Dynamics: -

Market Drivers:(Continuous rise of CVDs, and cardiac surgeries worldwide)

  • The continuously rising incidences of CVDs (cardiovascular diseases) is the one of the major factors that is propelling the overall growth of the market. According to the AHA (American Heart Association), CVDs had caused 868,662 deaths in 2017. In 2018, in the U.S, CHD (coronary heart diseases) was the primary cause of death (42.1%), followed by stroke (17.0%), high BP (11.0%), Cardiac failure (9.6%), arterial diseases (2.9%), and other CVDs (17.4%). 
  • Due to the increase of CVDs, the governments worldwide have increased their expenditure on the Cardiac Disease Management (like cardiac surgeries, cardiac resynchronization therapy, etc)which is highly fuelling the overall market growth globally. According to Lifespan Health System, approximately 500,000 open heart surgeries are conducted each year in the United States like coronary artery bypass and several other complex aortic surgeries. Also, in accordance with a new study by iData Research, in the United States each year more than 900,000 total cardiac surgeries are performed.
  • Apart from the cardiac disease management, the introduction of various kinds of pacemakers likeaicd pacemaker, iphone 12 pacemaker, micra leadless pacemaker, st jude medical pacemaker, single chamber pacemaker, Dual chamber pacemaker, Biventricular pacemaker, abbott pacemaker (Assurity and Endurity), and processes such as Electrocardiogram, Holter monitoring, and Echocardiogram, are highly facilitating the overall market growth.
  • Further, the highlyfavorable government policies, and the introduction of technologically upgraded pacemakers (MRI safe pacemakers, and leadless pacemakers) are highly stimulating the overall market growth.

 

Restraints: - (Rise in pacemaker infections)

The increase of various pacemaker infections, bradycardia, blood clots, Air leakage, and Twiddler’s Syndrome are some of the factors that are highly restraining the overall growth of this market.

 

Opportunities:(Production of High-End Pacemakers)

Nowadays, the global organizations are entirely focused on the manufacturing of high-end pacemakers (biventricular pacemakers) that comprehensively meets all the patient’s requirements thereby catering to customized care. These new innovations are widely enhancing the accuracy of workflow, and are also facilitating error reductionrates thereby creating ample opportunities for the market in future.

 

Global Cardiac Pacemaker Market Analysis(Segmentation Analysis): -

The Global Cardiac Pacemaker Industry segmentation is performed based on Product Outlook, Type, Applications, End-User, and Regions.

 

Based on Product Outlook

Implantable Cardiac Pacemakers

  • Dual Chamber
  • Single Chamber
  • Biventricular Chamber

External pacemakers

 

Based on Type

  • Conventional Pacemakers
  • MRI Compatible Pacemakers

 

Based on Applications

  • Arrhythmias
  •         -Heart Blockage
  •         -Atrial Fibrillation
  •        -Long QT Syndrome
  • Congestive Cardiac Failure
  • Others

 

Based on End-User

  • Hospitals & Cardiac Centers
  • ASCs (Ambulatory Surgical Centers)
  • Others

 

Based on Regions:

North America

  • U.S.
  • Mexico
  • Canada
  • Rest of North America

 

Europe

  • Switzerland
  • Russia
  • France
  • Germany
  • U.K
  • Finland
  • Turkey
  • Netherlands 
  • Belgium
  • Spain
  • Italy
  • Rest of Europe

 

Asia Pacific

  • China
  • India
  • Indonesia
  • South Korea
  • Thailand
  • Japan
  • Singapore
  • Malaysia
  • Philippines
  • Australia
  • New Zealand
  • Rest of APAC

 

LAMEA

  • Brazil
  • Saudi Arabia
  • Uruguay
  • Argentina
  • Rest of LAMEA

 

Based on Product Outlook, the ‘Implantable Cardiac Pacemakers’marketdominatedwith an overall share of approximately 63.75% in 2020. The rise in the adoption of these devices for arrhythmias, treatment of cardiac failure as well as the ongoing clinical trials processes are the key factors that are driving the overall growth of this segment.

Based on Type, the ‘Conventional Pacemakers’ held the largest market share of nearly 52.37% of the entire market. Continuous technological upgradations, small size and its high affordability, are the major factors driving the segment growth.

On the other hand, the ‘MRI Compatible Pacemakers’ held the fastest rate of growth throughout the forecasted period. In 2018, According to Mayo Foundation for Medical Education and Research, approximately 78.36% of patients who were having an implantable pacemaker needed an MRI during their lifetimes. Hence, the segment witnessed the highest rate of growth.

Based on Applications, the ‘Arrhythmias’ segment dominated the market with a total share of approximately 39.21 percent of the overall market in 2020.Factors such as excessive alcohol consumption, obesity, smoking, and other lifestyle disorders are contributing to the increase in risk of cardiac arrhythmia, which in turn is driving the overall growth of this segment.

Based on End-User, the ‘Hospitals & Cardiac Centers’ significantly dominated the market with a total revenue share of approximately 62.37% during the estimated period. Rise of cardiac patient admissions, and excellent reimbursement facilities during the surgeries, are the factors that are fuelling the growth of this segment.According to AHA (American Heart Association) the total number of cardiac patients is expected to rise approximately by 23.6 Mn by 2030.

Based on Region, North America significantly held the largest market share of nearly 43.78% throughout the estimated period.The pacemaker market in USA is expected to witness a healthy CAGR throughout the forecasted period.A continuous increase of the geriatric population with cardiac problems, rapid technological advancements (such as Bluetooth enabled pacemakers, MRI compatible pacemakers, etc) and improved regulatory approvals are stimulating the growth of the market in this region.

Asia Pacific held the fastest rate of growth during the forecasted period with a robust CAGR. The increase of fundings by the governments in the healthcare sector especially for cardiac diagnosis and treatment in countries like India, Japanand Chinaisalso accelerating the growth of this segment.

 

Global Cardiac Pacemaker Market: Competitive Landscape Analysis

An overall competitive landscape analysis is very essential for accumulating an accurate information regarding the crucial competitors that exist in the global market environment. The comparison is performed on the basis of total revenue generation,market initiatives, investment in R&D, a 360-degree company overview, market potential, company strengths and weaknesses, company financials, global presence, production sites, and facilities, production capacity, etc.

 

 

The list of key players that are included in the Global Cardiac Pacemaker Market report are:

  • Boston Scientific Corporation
  • Medtronic
  • Zoll Medical Corporation
  • MicroPort Scientific Corporation
  • Cook Medical
  • BIOTRONIK
  • MEDICO SpA
  • Pacetronix
  • Oscor Inc.
  • Osypka Medical GmbH
  • Lepu Medical
  • LivaNova
  • Pacetronix
  • MEDICO
  • Osypka Medical

 

Global Cardiac Pacemaker Market: Recent Developments

  • On May 2020, BIOTRONIK launched a home monitoring system for providing a safe and cost-effective management for patients with pacemakers.
  • On 21st January 2020, Medtronic announced FDA approval for its product Micra AV, which is the world’s smallest 2nd generation wireless pacemaker that is directly implanted into the heart.
  • On 29th April 2018, MicroPort completed the acquisition of Cardiac Rhythm Management Business from LivaNova. This would highly improvise its market penetrationacross the globe.

 

Key Cardiac Pacemaker Devices that are developed by leading market players

 

PRODUCT NAME

FUNCTION

COMPANY

 

 

ACCOLADE Pacing Systems

Provides the best options for MRI programmability. Its automatic features support AF detection, lead checks, and wireless remote monitoring in patient management thereby boosting the Boston scientific pacemaker market size and share.

 

 

Boston Scientific Corporation

 

AZURE PACEMAKER

Provides exclusive algorithms for accurately detecting and reducing the risk of atrial fibrillation thereby stimulating the Medtronic pacemaker market share.

 

Medtronic

 

 

 

PACE 300

It is the world’s first 3-chambered temporary cardiac pacemaker that is effectively designed to be used with the cardiac pacing lead systems for temporary atrial pacing. It is also implemented for therapeutic or prophylactic purposes.

 

 

 

 

 

 

Osypka Medical

Frequently Asked Question About This Report

N/A

1.   Introduction

       1.1.  Study Objective

       1.2.  Market Definition        

       1.3.  Study Scope

              1.3.1. Markets Covered

              1.3.2. Geographic Scope

              1.3.3. Years Considered

              1.3.4. Stakeholders

2.   Research Methodology

       2.1.  Data Procurement

       2.2.  Paid Database

              2.2.1. Secondary Data

                     2.2.1.1. Key Secondary sources

              2.2.2. Primary Data

                     2.2.2.1 Primary sources

                     2.2.2.2. Key industry insights

                     2.2.2.3. Primary interviews with experts

                     2.2.2.4. Key primary respondent list

       2.3.  Market Size Estimation

       2.4.  Bottom-Up and Top-Down Approaches

              2.4.1.       Bottom-Up Approach

                     2.4.1.1.            Approach for arriving at market size by bottom-up analysis

              2.4.2.       Top-Down Approach

                     2.4.2.1.            Approach for Capturing Market Size by Top-Down Analysis

       2.5.  Market Breakdown and Data Triangulation

       2.6.  Research Methodology

       2.7.  Risk Assessment

3.  Executive Summary

       3.1   Cardiac Pacemaker Market: Post-Covid-19

              3.1.1        Actual Scenario

              3.1.2        Pessimistic Scenario

              3.1.3        Optimistic Scenario

              3.1.4        Market Summary

4. Industry Outlook

       4.1   Market Snapshot

       4.2   Global Cardiac Pacemaker Market

              4.2.1        Global Cardiac Pacemaker market, 2020 – 2028 (USD Million)

       4.3   Regional Business Analysis

              4.3.1        Global Cardiac Pacemaker market, by region, 2020 - 2028 (USD Million)

       4.4   By Product Business Analysis

              4.4.1        Global Cardiac Pacemaker market,  By Product, 2020 - 2028 (USD Million)

       4.5   By Type Business Analysis

              4.5.1        Global Cardiac Pacemaker market, By Type, 2020 - 2028 (USD Million)

       4.6   Application Business Analysis

              4.6.1        Global Cardiac Pacemaker market, By Application, 2020 - 2028 (USD Million)

       4.6   End-User Business Analysis

              4.6.1        Global Cardiac Pacemaker market, By End-User, 2020 - 2028 (USD Million)

       4.7   Value Chain Analysis

       4.8   Market Variable Analysis

              4.8.1        Market Drivers Analysis

              4.8.2        Market Restraints Analysis

       4.9   Business Environment Analysis Tool

              4.9.1        Cardiac Pacemaker market PEST analysis

              4.9.2        Cardiac Pacemaker market Porter’s analysis

       4.10 Penetration & Growth Prospect Mapping

 

5. Market Dynamics

       5.1.  Introduction

       5.2.  Market Dynamics

              5.2.1.       Drivers

              5.2.2.       Restraints

              5.2.3.       Opportunities

              5.2.4.       Challenges

       5.3.  Impact of Covid-19 On Cardiac Pacemaker Market

       5.4.  Value Chain Analysis

       5.5.  Ecosystem

       5.6.  Patent Analysis

       5.7.  Trade Analysis

       5.8.  Tariff Analysis

       5.9.  Case Study Analysis

5.10.      Porter’s Five Forces Analysis

              5.10.1      Threat of New Entrants

              5.10.2      Threat of Substitutes

              5.10.3      Bargaining Power of Buyers

              5.10.4      Bargaining Power of Suppliers

              5.10.5      Degree of Competition

       5.11.               Product Analysis

              5.11.1.     Trends in Product (2014-2020)

              5.11.2.     Trends in Product (2021-2028)

       5.12.               Pricing Analysis

              5.12.1.     Average Price Trend Analysis (By region, By Countries)

6. Competitive & Vendor Landscape

       6.1.  Company Market Share Analysis

       6.2.  Manufacturers Cardiac Pacemaker Manufacturing Sites, Area Served, Product Type

       6.3.  Cardiac Pacemaker Market Competitive Situation and Trends

       6.4.  Manufacturers Mergers & Acquisitions, Expansion Plans

7. Global Cardiac Pacemaker Market:  By Product Segment Analysis

       7.1.  Introduction

       7.2.  Sales Volume & Revenue Analysis (2020-2028)

       7.3.  Implantable Cardiac Pacemakers

              7.3.1.       Implantable Cardiac Pacemakers market, 2020 - 2028 (USD Million)

                        7.3.1.1           Dual Chamber market, 2020 - 2028 (USD Million)

                        7.3.1.2           Single Chamber market, 2020 - 2028 (USD Million)

                        7.3.1.3           Biventricular Chamber market, 2020 - 2028 (USD Million)

       7.4.  External pacemakers

              7.4.1.       External pacemakers market, 2020 - 2028 (USD Million)

8. Global Cardiac Pacemaker Market: By Type Segment Analysis

       8.1.  Introduction

       8.2.  Sales Volume & Revenue Analysis (2020-2028)

       8.3.  Conventional Pacemakers

              8.3.1.       Conventional Pacemakers market, 2020 - 2028 (USD Million)

       8.4.  MRI Compatible Pacemakers

              8.4.1.       MRI Compatible Pacemakers market, 2020 - 2028 (USD Million)

9. Global Cardiac Pacemaker Market: By Application Segment Analysis

       9.1.  Introduction

       9.2.  Sales Volume & Revenue Analysis (2020-2028)

       9.3.  Arrhythmias

              9.3.1.       Arrhythmias market, 2020 - 2028 (USD Million)

                        9.3.1.1           Heart Blockage market, 2020 - 2028 (USD Million)

                        9.3.1.2           Atrial Fibrillation market, 2020 - 2028 (USD Million)

                        9.3.1.3           Long QT Syndrome market, 2020 - 2028 (USD Million)

       9.4.  Congestive Cardiac Failure

              9.4.1.       Congestive Cardiac Failure market, 2020 - 2028 (USD Million)

       9.5   Others

              9.5.1        Others market, 2020 - 2028 (USD Million)

10. Global Cardiac Pacemaker Market: By End-User Segment Analysis

       10.1. Introduction

       10.2. Sales Volume & Revenue Analysis (2020-2028)

       10.3. Hospitals & Cardiac Centers

              10.3.1.     Hospitals & Cardiac Centers market, 2020 - 2028 (USD Million)

       10.4. ASCs (Ambulatory Surgical Centers)

              10.4.1.     ASCs (Ambulatory Surgical Centers) market, 2020 - 2028 (USD Million)

       10.5 Others

              10.5.1      Others market, 2020 - 2028 (USD Million)

11. Global Cardiac Pacemaker Market: Regional Outlook

       11.1 North America

              11.1.1.     North America Cardiac Pacemaker market, By Product, 2020 - 2028 (USD Million)

              11.1.2.     North America Cardiac Pacemaker market, By Type, 2020 - 2028 (USD Million)

              11.1.3.     North America Cardiac Pacemaker market, by Application, 2020 - 2028 (USD Million)

              11.1.4.     North America Cardiac Pacemaker market, By End-User, 2020 - 2028 (USD Million)

 

              11.1.5.     North America Cardiac Pacemaker market, by Country, 2020 - 2028 (USD Million)

11.1.4.1.               U.S.

                     11.1.4.1.1.      U.S. Cardiac Pacemaker market, By Product, 2020 - 2028 (USD Million)

                     11.1.4.1.2.      U.S. Cardiac Pacemaker market, By Type, 2020 - 2028 (USD Million)

                     11.1.4.1.3.      U.S. Cardiac Pacemaker market, by Application, 2020 - 2028 (USD Million)

    11.1.4.2.      Canada

                     11.1.4.2.1.      Canada Cardiac Pacemaker market, By Product, 2020 - 2028 (USD Million)

                     11.1.4.2.2.      Canada Cardiac Pacemaker market, By Type, 2020 - 2028 (USD Million)

                     11.1.4.2.3.      Canada Cardiac Pacemaker market, by Application, 2020 - 2028 (USD Million)

11.2.      Europe

              11.2.1.     Europe Cardiac Pacemaker market, By Product, 2020 - 2028 (USD Million)

              11.2.1.     Europe Cardiac Pacemaker market, by  By End-User, 2020 - 2028 (USD Million)

         

              11.2.2.     Europe Cardiac Pacemaker market, By Type, 2020 - 2028 (USD Million)

              11.2.3.     Europe Cardiac Pacemaker market, by Application, 2020 - 2028 (USD Million)

              11.2.4.     Europe Cardiac Pacemaker market, by country, 2020 - 2028 (USD Million)

    11.2.4.1    U.K.

                     11.2.4.1.1.      U.K. Cardiac Pacemaker market, By Product, 2020 - 2028 (USD Million)

                     11.2.4.1.2.      U.K. Cardiac Pacemaker market, By Type, 2020 - 2028 (USD Million)

                     11.2.4.1.3.      U.K. Cardiac Pacemaker market, by Application, 2020 - 2028 (USD Million)

   11.2.4.2.            Germany

                     11.2.4.2.1.      Germany Cardiac Pacemaker market, By Product, 2020 - 2028 (USD Million)

                     11.2.4.2.2.      Germany Cardiac Pacemaker market, By Type, 2020 - 2028 (USD Million)

                     11.2.4.2.3.      Germany Cardiac Pacemaker market, by Application, 2020 - 2028 (USD Million)

   11.2.4.3.            France

                     11.2.4.3.1.      France Cardiac Pacemaker market, By Product, 2020 - 2028 (USD Million)

                     11.2.4.3.2.      France Cardiac Pacemaker market, By Type, 2020 - 2028 (USD Million)

                     11.2.4.3.3.      France Cardiac Pacemaker market, by Application, 2020 - 2028 (USD Million)

    11.2.4.4.           Rest of Europe

                     11.2.4.4.1.      Rest of Europe Cardiac Pacemaker market, By Product, 2020 - 2028 (USD Million)

                     11.2.4.4.2.      Rest of Europe Cardiac Pacemaker market, By Type, 2020 - 2028 (USD Million)

                     11.2.4.4.3.      Rest of Europe Cardiac Pacemaker market, by Application, 2020 - 2028 (USD Million)

       11.3.               Asia Pacific

              11.3.1.     Asia Pacific Cardiac Pacemaker market, By Product, 2020 - 2028 (USD Million)

              11.3.1.     Asia Pacific Cardiac Pacemaker market, By End-User, 2020 - 2028 (USD Million)

           

              11.3.2.     Asia Pacific Cardiac Pacemaker market, By Type, 2020 - 2028 (USD Million)

              11.3.3.     Asia Pacific Cardiac Pacemaker market, by Application, 2020 - 2028 (USD Million)

              11.3.4.     Asia Pacific Cardiac Pacemaker market, by country, 2020 - 2028 (USD Million)

   11.3.4.1.            China

                     11.3.4.1.1.      China Cardiac Pacemaker market, By Product, 2020 - 2028 (USD Million)

                     11.3.4.1.2.      China Cardiac Pacemaker market, By Type, 2020 - 2028 (USD Million)

                     11.3.4.1.3.      China Cardiac Pacemaker market, by Application, 2020 - 2028 (USD Million)

   11.3.4.2.            India

                     11.3.4.2.1.      India Cardiac Pacemaker market, By Product, 2020 - 2028 (USD Million)

                     11.3.4.2.2.      India Cardiac Pacemaker market, By Type, 2020 - 2028 (USD Million)

                     11.3.4.2.3.      India Cardiac Pacemaker market, by Application, 2020 - 2028 (USD Million)

   11.3.4.3.            Japan

                     11.3.4.3.1.      Japan Cardiac Pacemaker market, By Product, 2020 - 2028 (USD Million)

                     11.3.4.3.2.      Japan Cardiac Pacemaker market, By Type, 2020 - 2028 (USD Million)

                     11.3.4.3.3.      Japan Cardiac Pacemaker market, by Application, 2020 - 2028 (USD Million)

   11.3.4.4.            South Korea

                     11.3.4.4.1.      South Korea Cardiac Pacemaker market, By Product, 2020 - 2028 (USD Million)

                     11.3.4.4.2.      South Korea Cardiac Pacemaker market, By Type, 2020 - 2028 (USD Million)

                     11.3.4.4.3.      South Korea Cardiac Pacemaker market, by Application, 2020 - 2028 (USD Million)

11.3.4.5.               Rest of ASIA PACIFIC

                     11.3.4.5.1.      Rest of ASIA PACIFIC Cardiac Pacemaker market, By Product, 2020 - 2028 (USD Million)

                     11.3.4.5.2.      Rest of ASIA PACIFIC Cardiac Pacemaker market, By Type, 2020 - 2028 (USD Million)

                     11.3.4.5.3.      Rest of ASIA PACIFIC Cardiac Pacemaker market, by Application, 2020 - 2028 (USD Million)

       11.4.               Latin America

              11.4.1.     Latin America Cardiac Pacemaker market, By Product, 2020 - 2028 (USD Million)

              11.4.2.     Latin America Cardiac Pacemaker market, By Type, 2020 - 2028 (USD Million)

              11.4.3.     Latin America Cardiac Pacemaker market, by Application, 2020 - 2028 (USD Million)

              11.4.4.     Latin America Cardiac Pacemaker market, by country, 2020 - 2028 (USD Million)

11.4.4.1.               Brazil

                     11.4.4.1.1.      Brazil Cardiac Pacemaker market, By Product, 2020 - 2028 (USD Million)

                     11.4.4.1.2.      Brazil Cardiac Pacemaker market, By Type, 2020 - 2028 (USD Million)

                     11.4.4.1.3.      Brazil Cardiac Pacemaker market, by Application, 2020 - 2028 (USD Million)

11.4.4.2.               Mexico

                     11.4.4.2.1.      Mexico Cardiac Pacemaker market, By Product, 2020 - 2028 (USD Million)

                     11.4.4.2.2.      Mexico Cardiac Pacemaker market, By Type, 2020 - 2028 (USD Million)

                     11.4.4.2.3.      Mexico Cardiac Pacemaker market, by Application, 2020 - 2028 (USD Million)

                     11.4.4.3.          Rest of the Latin America

                     11.4.4.3.1.      Rest of the Latin America Cardiac Pacemaker market, By Product, 2020 - 2028 (USD Million)

                     11.4.4.3.2.      Rest of the Latin America Cardiac Pacemaker market, By Type, 2020 - 2028 (USD Million)

                     11.4.4.3.3.      Rest of the Latin America Cardiac Pacemaker market, by Application, 2020 - 2028 (USD Million)

       11.5.               MEA

              11.5.1.     MEA Cardiac Pacemaker market, By Product, 2020 - 2028 (USD Million)

              11.5.2.     MEA Cardiac Pacemaker market, By Type, 2020 - 2028 (USD Million)

              11.5.3.     MEA Cardiac Pacemaker market, by Application, 2020 - 2028 (USD Million)

              11.5.4.     MEA Cardiac Pacemaker market, By End-User, 2020 - 2028 (USD Million)

 

12. Competitive Landscape

       12.1 Boston Scientific Corporation.

              12.1.1.     Company overview

              12.1.2.     Financial performance

              12.1.3.     Product Portfolio Analysis

              12.1.4.     Business Strategy & Recent Development

       12.2. Medtronic.

              12.2.1.     Company overview

              12.2.2.     Financial performance

              12.2.3.     Product Portfolio Analysis

              12.2.4.     Business Strategy & Recent Development

       12.3. Zoll Medical Corporation

              12.3.1.     Company overview

              12.3.2.     Financial performance

              12.3.3.     Product Portfolio Analysis

              12.3.4.     Business Strategy & Recent Development

       12.4. MicroPort Scientific Corporation.

              12.4.1.     Company overview

              12.4.2.     Financial performance

              12.4.3.     Product Portfolio Analysis

              12.4.4.     Business Strategy & Recent Development

       12.5. Cook Medical

              12.5.1.     Company overview

              12.5.2.     Financial performance

              12.5.3.     Product Portfolio Analysis

              12.5.4.     Business Strategy & Recent Development

       12.6. BIOTRONIK.

              12.6.1.     Company overview

              12.6.2.     Financial performance

              12.6.3.     Product Portfolio Analysis

              12.6.4.     Business Strategy & Recent Development

       12.7. MEDICO SpA

              12.7.1.     Company overview

              12.7.2.     Financial performance

              12.7.3.     Product Portfolio Analysis

              12.7.4.     Business Strategy & Recent Development

       12.8. Pacetronix.

              12.8.1.     Company overview

              12.8.2.     Financial performance

              12.8.3.     Product Portfolio Analysis

              12.8.4.     Business Strategy & Recent Development

       12.9. Oscor Inc.

              12.9.1.     Company overview

              12.9.2.     Financial performance

              12.9.3.     Product Portfolio Analysis

              11.9.4.     Business Strategy & Recent Development

       12.10. Osypka Medical GmbH.

              12.10.1.  Company overview

              12.10.2.  Financial performance

              12.10.3.  Product Portfolio Analysis

              12.10.4.  Business Strategy & Recent Development

       12.11. Lepu Medical.

              12.11.1.  Company overview

              12.11.2.  Financial performance

              12.11.3.  Product Portfolio Analysis

              12.11.4.  Business Strategy & Recent Development

       12.12. LivaNova.

              12.12.1.  Company overview

              12.12.2.  Financial performance

              12.12.3.  Product Portfolio Analysis

              12.12.4.  Business Strategy & Recent Development

       12.13. Pacetronix

              12.13.1.  Company overview

              12.13.2.  Financial performance

              12.13.3.  Product Portfolio Analysis

              12.13.4.  Business Strategy & Recent Development

       12.14. MEDICO.

              12.14.1.  Company overview

              12.14.2.  Financial performance

              12.14.3.  Product Portfolio Analysis

              12.14.4.  Business Strategy & Recent Development

       12.15. Osypka Medical.

              12.15.1.  Company overview

              12.15.2.  Financial performance

              12.15.3.  Product Portfolio Analysis

              12.15.4.  Business Strategy & Recent Development

 

List of Tables (68 Tables)

TABLE 1.  Cardiac Pacemaker MARKET,  By Product, 2020-2028 (USD Million)

TABLE 2.  Cardiac Pacemaker MARKET  FOR Implantable Cardiac Pacemakers, BY REGION, 2020-2028 (USD Million)

TABLE 3.  Cardiac Pacemaker MARKET FOR Dual Chamber, BY REGION, 2020-2028 (USD Million)

TABLE 4.  Cardiac Pacemaker MARKET FOR Single Chamber, BY REGION, 2020-2028 (USD Million)

TABLE 5.  Cardiac Pacemaker MARKET FOR Biventricular Chamber, BY REGION, 2020-2028 (USD Million)

TABLE 6.  Cardiac Pacemaker MARKET FOR External pacemakers, BY REGION, 2020-2028 (USD Million)

TABLE 8. Cardiac Pacemaker MARKET, By Type, 2020-2028 (USD Million)

TABLE 9. Cardiac Pacemaker MARKET FOR Conventional Pacemakers, BY REGION, 2020-2028 (USD Million)

TABLE 10. Cardiac Pacemaker MARKET FOR MRI Compatible Pacemakers, BY REGION, 2020-2028 (USD Million)

TABLE 11. Cardiac Pacemaker MARKET, BY APPLICATION, 2020-2028 (USD Million)

TABLE 12. Cardiac Pacemaker MARKET FOR Arrhythmias, BY REGION, 2020-2028 (USD Million)

TABLE 13. Cardiac Pacemaker MARKET FOR Heart Blockage, BY REGION, 2020-2028 (USD Million)

TABLE 14. Cardiac Pacemaker MARKET FOR Atrial Fibrillationg, BY REGION, 2020-2028 (USD Million)

TABLE 15. Cardiac Pacemaker MARKET FOR Long QT Syndrome, BY REGION, 2020-2028 (USD Million)

TABLE 16. Cardiac Pacemaker MARKET FOR Congestive Cardiac Failure, BY REGION, 2020-2028 (USD Million)

TABLE 17. Cardiac Pacemaker MARKET FOR Others, BY REGION, 2020-2028 (USD Million)

TABLE 18. Cardiac Pacemaker MARKET, By End-user, 2020-2028 (USD Million)

TABLE 19. Cardiac Pacemaker MARKET FOR Hospitals & Cardiac Centers, BY REGION, 2020-2028 (USD Million)

TABLE 20. Cardiac Pacemaker MARKET FOR ASCs (Ambulatory Surgical Centers), BY REGION, 2020-2028 (USD Million)

TABLE 21. Cardiac Pacemaker MARKET FOR Others, BY REGION, 2020-2028 (USD Million)

TABLE 22. Cardiac Pacemaker MARKET, BY REGION, 2020-2028 (USD Million)

TABLE 23. NORTH AMERICA Cardiac Pacemaker MARKET, BY COUNTRY, 2020-2028 (USD Million)

TABLE 24. NORTH AMERICA Cardiac Pacemaker MARKET,  By Product, 2020-2028 (USD Million)

TABLE 25. NORTH AMERICA Cardiac Pacemaker MARKET, By Type, 2020-2028 (USD Million)

TABLE 26. NORTH AMERICA Cardiac Pacemaker MARKET, BY APPLICATION, 2020-2028 (USD Million)

TABLE 27. EUROPE Cardiac Pacemaker MARKET, BY COUNTRY, 2020-2028 (USD Million)

TABLE 28. EUROPE Cardiac Pacemaker MARKET,  By Product, 2020-2028 (USD Million)

TABLE 29. EUROPE Cardiac Pacemaker MARKET, By Type, 2020-2028 (USD Million)

TABLE 30. EUROPE Cardiac Pacemaker MARKET, BY APPLICATION, 2020-2028 (USD Million)

TABLE 31. ASIA-PACIFIC Cardiac Pacemaker MARKET, BY COUNTRY, 2020-2028 (USD Million)

TABLE 32. ASIA-PACIFIC Cardiac Pacemaker MARKET,  By Product, 2020-2028 (USD Million)

TABLE 33. ASIA-PACIFIC Cardiac Pacemaker MARKET, By Type, 2020-2028 (USD Million)

TABLE 34. ASIA-PACIFIC Cardiac Pacemaker MARKET, BY APPLICATION, 2020-2028 (USD Million)

TABLE 35. LAMEA Cardiac Pacemaker MARKET, BY COUNTRY, 2020-2028 (USD Million)

TABLE 36. LAMEA Cardiac Pacemaker MARKET,  By Product, 2020-2028 (USD Million)

TABLE 37. LAMEA Cardiac Pacemaker MARKET, By Type, 2020-2028 (USD Million)

TABLE 38. LAMEA Cardiac Pacemaker MARKET, BY APPLICATION, 2020-2028 (USD Million)

TABLE 39. Boston Scientific Corporation: COMPANY SNAPSHOT

TABLE 40. Boston Scientific Corporation: OPERATING SEGMENTS

TABLE 41. Medtronic: COMPANY SNAPSHOT

TABLE 42. Medtronic: OPERATING SEGMENTS

TABLE 43. Zoll Medical Corporation: COMPANY SNAPSHOT

TABLE 44. Zoll Medical Corporation: OPERATING SEGMENTS

TABLE 45. MicroPort Scientific Corporation: COMPANY SNAPSHOT

TABLE 46. MicroPort Scientific Corporation : OPERATING SEGMENTS

TABLE 47. Cook Medical: COMPANY SNAPSHOT

TABLE 48. Cook Medical: OPERATING SEGMENTS

TABLE 49. BIOTRONIK: COMPANY SNAPSHOT

TABLE 50. BIOTRONIK : OPERATING SEGMENTS

TABLE 51. MEDICO SpA: COMPANY SNAPSHOT

TABLE 52. MEDICO SpA: OPERATING SEGMENTS

TABLE 53. Pacetronix: COMPANY SNAPSHOT

TABLE 54. Pacetronix: OPERATING SEGMENTS

TABLE 55. Oscor Inc.: COMPANY SNAPSHOT

TABLE 56. Oscor Inc.: OPERATING SEGMENTS

TABLE 57. Osypka Medical GmbH : COMPANY SNAPSHOT

TABLE 58. Osypka Medical GmbH : OPERATING SEGMENTS

TABLE 59. Lepu Medical : COMPANY SNAPSHOT

TABLE 60. Lepu Medical : OPERATING SEGMENTS

TABLE 61. LivaNova: COMPANY SNAPSHOT

TABLE 62. LivaNova: OPERATING SEGMENTS

TABLE 63. Pacetronix: COMPANY SNAPSHOT

TABLE 64. Pacetronix: OPERATING SEGMENTS

TABLE 65. MEDICO: COMPANY SNAPSHOT

TABLE 66. MEDICO: OPERATING SEGMENTS

TABLE 67. Osypka Medical: COMPANY SNAPSHOT

TABLE 68. Osypka Medical: OPERATING SEGMENTS

 

List of Figures (24 Figures)

Figure 1 Cardiac Pacemaker Market: Research Methodology Steps

Figure 2 Research Design

Figure 3 Breakdown of Primaries: Cardiac Pacemaker Market

Figure 4 Research Methodology: Hypothesis Building

Figure 5 Cardiac Pacemaker Market: Product-Based Estimation

Figure 6 Top 15 Companies with Highest No. Of Patent in Last 9 Years

Figure 7 No. Of Patents Granted Per Year, 2019–2020

Figure 8 Import Data for Cardiac Pacemaker, By Country, 2016–2020 (USD Thousand)

Figure 9 Export Data for Cardiac Pacemaker, By Country, 2016–2020 (USD Thousand)

Figure 10 Data Triangulation Methodology

Figure 11 Cardiac Pacemaker Market, By Type, 2019 vs. 2025 (USD Million)

Figure 12 Cardiac Pacemaker Market Share, By Application, 2019 vs. 2025 (USD Million)

Figure 13 Cardiac Pacemaker Market Share,  By Product, 2019 vs. 2025 (USD Million)

Figure 14 Cardiac Pacemaker Market Share,  By End-User, 2019 vs. 2025 (USD Million)

Figure 15 Geographical Snapshot of the Cardiac Pacemaker Market

Figure 16 Implantable Cardiac Pacemakers to Witness Higher CAGR in Cardiac Pacemaker Market for Product Segment during Forecast Period.

Figure 17 Conventional Pacemakers to Witness Higher CAGR in Cardiac Pacemaker Market for Type Segment during Forecast Period.

Figure 18 Hospitals & Cardiac Centers to Witness Higher CAGR in Cardiac Pacemaker Market for End-User Segment during Forecast Period.

Figure 19 Arrhythmias to Witness Higher CAGR in Cardiac Pacemaker Market for Applications Segment during Forecast Period.

Figure 20 North America Accounted for the Largest Share of the Cardiac Pacemaker Market, By Regional Basis, in 2019

Figure 21 Cardiac Pacemaker Market: Drivers, Restraints, Opportunities, and Challenges

Figure 22 North America: Cardiac Pacemaker Market Snapshot

Figure 23 Asia Pacific: Cardiac Pacemaker Market Snapshot

Figure 24 Vendor Dive: Evaluation Overview